You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Merck
AstraZeneca
Medtronic
Boehringer Ingelheim
Harvard Business School

Last Updated: July 16, 2020

DrugPatentWatch Database Preview

ZTLIDO Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Ztlido patents expire, and when can generic versions of Ztlido launch?

Ztlido is a drug marketed by Scilex Pharms Inc and is included in one NDA. There are three patents protecting this drug.

This drug has thirteen patent family members in eight countries.

The generic ingredient in ZTLIDO is lidocaine. There are twenty-nine drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the lidocaine profile page.

US ANDA Litigation and Generic Entry Outlook for Ztlido

A generic version of ZTLIDO was approved as lidocaine by ACTAVIS LABS UT INC on August 23rd, 2012.

  Start Trial

Drug patent expirations by year for ZTLIDO
Drug Prices for ZTLIDO

See drug prices for ZTLIDO

Recent Clinical Trials for ZTLIDO

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Scilex Pharmaceuticals, Inc.Phase 1

See all ZTLIDO clinical trials

Pharmacology for ZTLIDO

US Patents and Regulatory Information for ZTLIDO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Scilex Pharms Inc ZTLIDO lidocaine PATCH;TOPICAL 207962-001 Feb 28, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Scilex Pharms Inc ZTLIDO lidocaine PATCH;TOPICAL 207962-001 Feb 28, 2018 RX Yes Yes   Start Trial   Start Trial   Start Trial
Scilex Pharms Inc ZTLIDO lidocaine PATCH;TOPICAL 207962-001 Feb 28, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Scilex Pharms Inc ZTLIDO lidocaine PATCH;TOPICAL 207962-001 Feb 28, 2018 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
AstraZeneca
Medtronic
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.